首页> 外文期刊>Heart >Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
【24h】

Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk

机译:估计的10年心血管疾病死亡率严重低估了总体心血管疾病风险

获取原文
获取原文并翻译 | 示例
           

摘要

Objective The European Society of Cardiology's prevention guideline suggests that the risk of total (fatal plus non-fatal) cardiovascular disease (CVD) may be calculated from the risk of CVD mortality using a fixed multiplier (3×). However, the proposed multiplier has not been validated. We investigated the ratio of total CVD to CVD mortality in a large population-based cohort. Methods CVD mortality and total CVD (fatal plus non-fatal CVD requiring hospitalisation) were analysed using Kaplan-Meier estimates among 24 014 men and women aged 39-79 years without baseline CVD or diabetes mellitus in the prospective population-based European Prospective Investigation of Cancer and Nutrition-Norfolk cohort. CVD outcomes included death and hospitalisations for ischaemic heart disease, heart failure, cerebrovascular disease, peripheral artery disease or aortic aneurysm. The main study outcome was the ratio of 10-year total CVD to 10-year CVD mortality stratified by age and sex. Results Ten year CVD mortality was 3.9% (900 CVD deaths, 95% Cl 3.6% to 4.1%); the rate of total CVD outcomes was 21.2% (4978 fatal or non-fatal CVD outcomes, 95% Cl 20.7% to 21.8%). The overall ratio of total CVD to CVD mortality was 5.4. However, we found major differences in this ratio when stratified by gender and age. In young women (39-50 years), the ratio of total CVD to CVD mortality was 28.5, in young men (39-50 years) 11.7. In the oldest age group, these ratios were considerably lower (3.2 in women and 2.4 in men aged 75-79 years). Conclusions The relationship between 10-year total CVD and CVD mortality is dependent on age and sex, and cannot be estimated using a fixed multiplier. Using CVD mortality to estimate total CVD risk leads to serious underestimation of risk, particularly in younger age groups, and particularly in women.
机译:目的欧洲心脏病学会的预防指南建议,可以使用固定乘数(3x)从CVD死亡的风险中计算总(致命与非致命)心血管疾病(CVD)的风险。但是,建议的乘数尚未得到验证。我们调查了大型人群中总CVD死亡率与CVD死亡率的比率。方法采用前瞻性人群基于欧洲前瞻性研究的欧洲前瞻性调查对24 014名无基线CVD或糖尿病的男性和女性中CVD死亡率和总CVD(需要住院的致命和非致命CVD)进行了分析。癌症与营养-诺福克队列研究。 CVD结果包括缺血性心脏病,心力衰竭,脑血管疾病,外周动脉疾病或主动脉瘤的死亡和住院。主要研究结果是按年龄和性别分层的10年总CVD与10年CVD死亡率之比。结果十年CVD死亡率为3.9%(900 CVD死亡率,95%Cl 3.6%至4.1%);总CVD结果的发生率为21.2%(致命或非致命CVD结果为4978,95%的CI为20.7%至21.8%)。总CVD与CVD死亡率的总比率为5.4。但是,我们发现按性别和年龄分层时,该比例存在重大差异。在年轻女性(39-50岁)中,总CVD与CVD死亡率之比为28.5,在年轻男性(39-50岁)中为11.7。在最高年龄组中,这些比例要低得多(75-79岁的女性为3.2,男性为2​​.4)。结论10年总CVD与CVD死亡率之间的关系取决于年龄和性别,无法使用固定的乘数估算。使用CVD死亡率来估计总CVD风险会导致风险的严重低估,尤其是在较年轻的年龄组,尤其是女性中。

著录项

  • 来源
    《Heart》 |2016年第1期|63-68|共6页
  • 作者单位

    Department of Cardiology, Academic Medical Center, University of Amsterdam, P.O. Box 22660, Amsterdam 1100 DD, The Netherlands;

    Department of Cardiology, Academic Medical Center-University of Amsterdam, Amsterdam, The Netherlands;

    Department of Cardiology, Academic Medical Center-University of Amsterdam, Amsterdam, The Netherlands;

    Department of Cardiology, Academic Medical Center-University of Amsterdam, Amsterdam, The Netherlands;

    MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK;

    Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, UK;

    Department of Cardiology, Academic Medical Center-University of Amsterdam, Amsterdam, The Netherlands;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号